Drug Discovery Collaborations

The Company’s scientists are discovering proteins from humans and human pathogens that are potentially good drugs, drug targets, and/or markers for drug toxicity. Protein Pathways’ research staff is identifying these proteins using its proprietary ProNexus technology.

Our technologies are being used to develop drug discovery collaborations with pharmaceutical companies. Lists of novel targets and their corresponding drug leads, as well as markers, will be patented and developed in combination with pharmaceutical and large biotechnology companies.